Journal of Infection in Developing Countries

Papers
(The H4-Index of Journal of Infection in Developing Countries is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Shifts in hospital-associated pathogens and prevalence trends of carbapenem-resistant Escherichia coli infections, 2021–2023104
Hematological profile among cutaneous leishmaniasis patients before and after treatment with sodium stibogluconate in Diyala, Iraq42
Sequels of COVID-19 in nephrology. Chronic kidney patients are more prone to hemodialysis need and mortality38
Impact of vaccination on ICU admissions of hospitalized COVID-19 patients in a country with a heterologous vaccine policy32
Impact of the COVID-19 pandemic on the temporal trend of indicators for access to tuberculosis diagnosis: A systematic review27
Successful treatment of peritonitis caused by Acremonium species without catheter removal: Case report and literature review24
Optimized Case Finding of tuberculosis among key populations in Ukraine. A follow up study21
Assessing COVID-19 outcomes among healthcare workers: a retrospective study21
Factors associated with deaths from COVID-19 in a region of northeastern Brazil21
A study of anti-SARS-CoV-2 antibody positivity in Duhok City, Iraq21
Characterization of extended-spectrum beta-lactamase and carbapenemase genes in bacteria from environment in Burkina Faso20
Alert for pharynx-centered gastrointestinal and respiratory cross-infection and cryptic cross-transmission routes of 2019-nCoV20
Surgical output within the Fast Track Initiative against trachoma in Amhara region, Ethiopia19
The efficiency of selective pooling strategy in a COVID-19 diagnostic laboratory19
Importance of evaluation of heart-type fatty acid binding protein (H-FABP) in COVID-19 Patients18
Outcomes and mortality risk scoring for infections caused by carbapenem-resistant Escherichia coli and Klebsiella pneumoniae18
Evaluation of the impact of Shigella virulence genes on the basis of clinical features observed in patients with shigellosis18
0.16565012931824